Please provide your email address to receive an email when new articles are posted on . Adverse events reported with ENV-101 have been seen with other hedgehog inhibitors. Another trial is already ...

Children with lesions on the top or back of the tongue often face significant challenges with eating and speaking. With ...

New research has identified a protein that could serve as both a biomarker and therapeutic target to weaken stem-like cancer ...

Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul ...